Search Results
May 19, 2026, 16:38 ET VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME
Department of War and the Biomedical Advanced Research and Development Authority (BARDA) in a joint briefing held on May 14, 2026. The session was Valion Bio's second engagement with senior Department of War officials, following the Company's April 28, 2026, Pentagon briefing on Entolimod.
More news about: Valion Bio, Inc.
May 19, 2026, 16:00 ET Illinois Humanities to Honor Statewide Leaders at Public Humanities Awards
2026 Public Humanities Awards, visit www.ilhumanities.org/pha. Full honoree bios will be available at www.ilhumanities.org/you-are-invited-public-humanities-awards-2026.
More news about: Illinois Humanities
May 19, 2026, 13:59 ET Matter Bio Files First IND for Lm-LLO-TT, Advancing First-in-Human Phase 1/2a Study in Pancreatic Cancer
IND submission marks Matter Bio's transition toward clinical stage and advances its lead Listeria-based immunotherapy into one of oncology's highest-need indicationsSAN FRANCISCO, May 19, 2026 /PRNewswire/ --
More news about: Matter Bio
May 19, 2026, 08:03 ET Trevelino/Keller Launches Exec-AI™, a New Service Measuring How Executive Visibility Drives Company Visibility Across AI Platforms
weighting reflects how AI models source their answers. Models lean heavily on encyclopedic and reference content (Wikipedia, Bloomberg, Forbes, association bios), surface trade and mainstream press as evidence of authority and increasingly retrieve LinkedIn POV content and podcast transcripts as proxies for expertise.
More news about: Trevelino/Keller
May 18, 2026, 23:59 ET GIGABYTE lança as novas edições B850 Ari para atender à crescente demanda das comunidades de anime e de montagem de PCs
CPU, enquanto odesign de PCB orientado por IA melhora a integridade do sinal por meio de simulação e ajuste baseados em IA. Além disso, o HyperTune BIOS utiliza otimização assistida por IA para ajustar o desempenho da memória e do sistema, proporcionando uma experiência de computaciona mais ágil e estável.
More news about: GIGABYTE
May 18, 2026, 23:56 ET GIGABYTE stellt neue B850 Ari-Editionen für Anime- und PC-DIY-Fans vor
optimiert. Ergänzend kann ein KI-gestütztes PCB-Design die Signalintegrität durch Simulation und Tuning verbessern. Darüber hinaus nutzt das HyperTune-BIOS KI-gestützte Optimierungsfunktionen zur Feinabstimmung der Speicher- und Systemleistung, um ein reaktionsschnelleres und stabileres Computererlebnis
More news about: GIGABYTE
May 18, 2026, 11:34 ET AMI Announces a Shift-Left Initiative to De-Risk SoC Development for Arm Total Design in Collaboration with Arm and Synopsys
Reduces custom silicon design costs, shortens product TTM by months, mitigates capital and complexity risks."AMI's efforts enabling firmware and BIOS validation on emulation using Synopsys ZeBu® provides powerful shift‑left capabilities to the Arm Total Design ecosystem," said Tran Nguyen, VP, Multi-Die
More news about: AMI
May 18, 2026, 08:00 ET Roche Highlights Robust Performance of Ellis Bio SuperMethyl™ Kits in New Tech Spotlight Evaluating Five Low‑Input cfDNA Methyl‑Seq Workflows
Max is based on Ellis Bio's proprietary Ultra‑Mild Bisulfite Sequencing (UMBS) chemistry, designed to minimize DNA degradation while maintaining high conversion efficiency, and is currently available through Ellis Bio's Early Access program. SuperMethyl Fast utilizes Ellis Bio's Ultra-Fast Bisulfite Sequencing
More news about: Ellis Bio Inc
May 18, 2026, 06:30 ET GIGABYTE ra mắt phiên bản B850 Ari Editions mới nhằm đáp ứng nhu cầu ngày càng tăng từ cộng đồng anime và người dùng tự build PC
cách thông minh, trong khi thiết kế PCB AI-Driven giúp cải thiện chất lượng tín hiệu thông qua mô phỏng và tinh chỉnh bằng AI. Ngoài ra, HyperTune BIOS tận dụng tối ưu hóa bằng AI để tinh chỉnh hiệu năng bộ nhớ và hệ thống, mang lại trải nghiệm điện toán phản hồi nhanh và ổn định hơn.Để
More news about: GIGABYTE
May 18, 2026, 06:28 ET GIGABYTE、アニメやPC DIYコミュニティからの高まる需要に応える新B850 神鷹凛モデルを発表
Corsa」テクノロジーは、メモリとCPUのオーバークロック性能をインテリジェントに最適化する「AI Snatch」を統合しており、「AI-Driven PCB Design」はAIシミュレーションとチューニングによりシグナルインテグリティを強化します。さらに、「HyperTune BIOS」はAIアシスト最適化を活用してメモリとシステムパフォーマンスを微調整し、より応答性が高く安定したコンピューティング体験を可能にします。組み立てプロセスをさらに効率化するために、B850 AORUS ELITE-Pモデルには、「EZ-DIY」の革新的な機能がフル装備されています。特許取得済みの「M.2 EZ-Flex」設計は、柔軟なサーマルベースプレートによりSSDの冷却効率を向上させ、「M.2
More news about: GIGABYTE
May 15, 2026, 03:07 ET 技嘉推出融合動漫美學與 AI 效能強化 B850 Ari 特仕版主機板
處理器，也能透過此獨家技術將效能提升至接近 Ryzen™ X3D 系列的遊戲表現。AI 強化的 D5 Bionic Corsa 技術則整合 AI Snatch 智慧超頻功能，可最佳化記憶體與處理器超頻表現；同時透過 AI 模擬與調校 PCB 設計強化訊號完整性。此外，HyperTune BIOS 也導入 AI 輔助優化記憶體與系統效能，帶來更高效且穩定的運算體驗。為進一步簡化電腦組裝流程，B850 AORUS ELITE-P 特仕版全面搭載 EZ-DIY 創新設計。專利 M.2 EZ-Flex 可透過彈性散熱底板提升 SSD 散熱效率；M.2 EZ-Latch Click
More news about: GIGABYTE
May 15, 2026, 03:00 ET GIGABYTE Launches New B850 Ari Editions to Respond to the Growing Demand from Anime and PC DIY Communities
and CPU overclocking performance, while the AI-Driven PCB Design enhances signal integrity through AI simulation and tuning. In addition, HyperTune BIOS leverages AI-assisted optimization to fine-tune memory and system performance, enabling a more responsive and stable computing experience.To
More news about: GIGABYTE
May 15, 2026, 03:00 ET GIGABYTE Launches New B850 Ari Editions to Respond to the Growing Demand from Anime and PC DIY Communities
and CPU overclocking performance, while the AI-Driven PCB Design enhances signal integrity through AI simulation and tuning. In addition, HyperTune BIOS leverages AI-assisted optimization to fine-tune memory and system performance, enabling a more responsive and stable computing experience.To
More news about: GIGABYTE
May 14, 2026, 16:31 ET Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform
treatments for neutropenia, which is most commonly caused by chemotherapy, and a state of T-cell dysfunction known as lymphocyte exhaustion. Valion Bio's wholly owned subsidiary, Velocity Bioworks, is a full-service contract development manufacturing organization (CDMO) offering biomanufacturing services
More news about: Valion Bio, Inc.
May 14, 2026, 16:05 ET VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
underserved domestic Phase I and Phase II biologics manufacturing market and is expected to function both as a cost and timeline accelerant for Valion Bio's internal pipeline and, increasingly, as a stand-alone source of revenue and operating leverage."Beyond Entolimod's role in radiation defense,
More news about: Valion Bio, Inc.
May 14, 2026, 09:00 ET A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach
biotech companies.[3] The Company's Cell-in-a-Box® technology forms the foundation of the encapsulation approach across both Avaí Bio's α-Klotho program and the Company's diabetes program — which is focused on developing an insulin-producing cell line and encapsulating those cells inside
More news about: Equity Insider
May 14, 2026, 08:00 ET Jetstream Venture Fund Invests in Wonderlab Bio, Expanding its High-Growth HealthTech Portfolio
opportunities. This strategic investment highlights Jetstream's commitment to backing transformative technologies across multiple sectors, positioning Wonderlab Bio's groundbreaking regenerative medicine alongside the fund's existing investments in aerospace (SpaceX) and artificial intelligence (Shield AI). Revolutionizing
More news about: Jetstream Venture Fund
May 13, 2026, 12:16 ET Non-Animal Alternative Testing Market Size to Reach $29.4 Billion by 2030, Globally, at 13.5% CAGR: Allied Market Research
million Series B investment round ($10 million base by Bayland Capital) and April 2025 CN Bio Innovations The funding will support the scale-up of CN Bio's liver-on-chip and multi-organ testing platforms in response to growing pharmaceutical and regulatory interest for human-relevant, non-animal preclinical
More news about: Allied Market Research
May 13, 2026, 08:15 ET FORTUNE 100 EXECUTIVE LAUNCHES AT THE BRINK, A PODCAST ABOUT MOMENTS THAT CHANGE EVERYTHING
[email protected], atthebrinkmedia.comErica Brinker is available for interviews upon request. High-resolution photography, episode previews and guest bios are available in the press kit.LINKSAt the Brink MediaWebsite:
More news about: At the Brink Media
May 12, 2026, 10:00 ET Cizzle Bio CEO Bill Behnke Participates in National Oncology Commercialization Panel at City of Hope's 25th Ci4CC Summit
translational oncology underscores the collaborative effort required to bring meaningful innovation from bench to bedside."Behnke also discussed Cizzle Bio's progress toward the near-term launch of its innovative early cancer detection biomarker blood tests for licensed U.S. healthcare providers.The
More news about: Cizzle Bio
May 11, 2026, 16:01 ET HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
settings. The addition of Surf Bio's polymer-based hyperconcentration technology further broadens the range of biologics that can be delivered subcutaneously, meaningfully expanding the scope of opportunities across therapeutic modalities. Together, HyperconTM and Surf Bio's technology complement ENHANZE®
More news about: Halozyme Therapeutics, Inc.
May 11, 2026, 09:13 ET Transpire Bio's ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
company to file an ANDA for the high-strength product with a Paragraph IV certification under the provisions of the Hatch-Waxman Act. Should Transpire Bio's ANDA be approved by the FDA, Transpire Bio believes it will be eligible for 180 days of market exclusivity.In the U.S., Trelegy® Ellipta®
More news about: Transpire Bio
May 11, 2026, 08:01 ET Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026
treatments for neutropenia, which is most commonly caused by chemotherapy, and a state of T-cell dysfunction known as lymphocyte exhaustion. Valion Bio's wholly owned subsidiary, Velocity Bioworks, is a full-service contract development and manufacturing organization (CDMO) offering biomanufacturing services
More news about: Valion Bio, Inc.
May 07, 2026, 09:00 ET Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets
settings. The addition of Surf Bio's polymer‑based hyperconcentration technology further broadens the range of biologics that can be delivered subcutaneously, meaningfully expanding the scope of opportunities across therapeutic modalities. Together, Hypercon™ and Surf Bio's technology complement ENHANZE®
More news about: Halozyme Therapeutics, Inc.
May 06, 2026, 08:08 ET Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™
matter of hours.Today's ribbon cutting marks the operational beginning of Velocity Bioworks as both an internal manufacturing engine for Valion Bio's pipeline and an emerging contract development and manufacturing organization (CDMO) serving third-party biologics clients.About Valion Bio,
More news about: Valion Bio, Inc.